SA PRO
Free Account
Themes
West Pharmaceutical Services, Inc.WSTNYSE
Loading
OverviewIntelligenceChartsNews

Analyst Sentiment

Analysts lean bullish — 71% recommend buying.

Consensus Rating
Buy
14 analysts·Moderate coverage
71%
Rating Distribution
Strong Buy
00%
Buy
1071%
Hold
321%
Sell
17%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see moderate upside — consensus target 21% higher.

Bear Case
$265.00
+6%
Consensus
$304.43
+21%
Bull Case
$340.00
+35%
Price Range14 analysts
Low
Consensus
High
$265.00
$340.00
Current Target
Current Price
$251.03
Upside to Target
$53.40

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Feb 13, 2026UBS
West Pharmaceutical price target lowered to $340 from $355 at UBS
Target:$340.00
+37.9%from $246.60
Feb 13, 2026Deutsche Bank
West Pharmaceutical price target raised to $315 from $310 at Deutsche Bank
Target:$315.00
+27.3%from $247.49
Feb 13, 2026Barclays
West Pharmaceutical price target lowered to $265 from $325 at Barclays
Target:$265.00
+8.8%from $243.61
Feb 10, 2026Jefferies
West Pharmaceutical price target lowered to $295 from $365 at Jefferies
Target:$295.00
+18.0%from $249.97
Feb 3, 2026Evercore ISI
West Pharmaceutical price target lowered to $320 from $390 at Evercore ISI
Target:$320.00
+34.5%from $237.88
Dec 1, 2025Morgan Stanley
West Pharmaceutical initiated with an Equal Weight at Morgan Stanley
Target:$285.00
+4.0%from $274.14
Oct 27, 2025Barclays
West Pharmaceutical price target raised to $325 from $275 at Barclays
Target:$325.00
+10.7%from $293.62
Oct 24, 2025UBS
West Pharmaceutical price target raised to $355 from $320 at UBS
Target:$355.00
+15.5%from $307.25
Oct 24, 2025Deutsche Bank
West Pharmaceutical price target raised to $345 from $305 at Deutsche Bank
Target:$345.00
+13.2%from $304.74
Oct 23, 2025Evercore ISI
West Pharmaceutical price target raised to $390 from $350 at Evercore ISI
Target:$390.00
+26.1%from $309.28
Oct 7, 2025Evercore ISI
West Pharmaceutical added to 'Tactical Outperform' list at Evercore ISI
Target:$350.00
+30.6%from $268.07
Oct 2, 2025Barclays
West Pharmaceutical price target raised to $275 from $260 at Barclays
Target:$275.00
+1.3%from $271.42
Sep 15, 2025Redburn Partners
West Pharmaceutical initiated with a Buy at Rothschild & Co Redburn
Target:$311.00
+20.8%from $257.53
Jun 24, 2025Barclays
West Pharmaceutical initiated with an Equal Weight at Barclays
Target:$245.00
+10.0%from $222.68
Nov 19, 2024Jefferies
Jefferies Reiterates Buy Rating on West Pharmaceutical (WST)
Target:$393.00
+36.5%from $287.85
Feb 7, 2024Jefferies
Jefferies Upgrades West Pharmaceutical (WST) to Buy as 'organic growth is correlated to injectable drug approvals'
Target:$536.00
+29.8%from $413.00
Dec 14, 2022Deutsche Bank
Deutsche Bank Initiates Coverage On West Pharmaceutical Servs with Hold Rating, Announces Price Target of $250
Target:$250.00
-0.8%from $251.90
Nov 30, 2022UBS
UBS Initiates Coverage On West Pharmaceutical Servs with Neutral Rating, Announces Price Target of $250
Target:$250.00
+12.2%from $222.84

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance